CELLULARLINE SPA (CELL.MI) Stock Fundamental Analysis
BIT:CELL - IT0005244618 - Common Stock
3.12 EUR
-0.01 (-0.48%)
CELL gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 28 industry peers in the Technology Hardware, Storage & Peripherals industry. CELL has an excellent financial health rating, but there are some minor concerns on its profitability. CELL is valued quite cheap, while showing a decent growth score. This is a good combination!
1. Profitability
1.1 Basic Checks
In the past year CELL was profitable.
CELL had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CELL reported negative net income in multiple years.
CELL had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
CELL's Return On Assets of 2.42% is fine compared to the rest of the industry. CELL outperforms 60.71% of its industry peers.
CELL has a better Return On Equity (3.98%) than 60.71% of its industry peers.
Looking at the Return On Invested Capital, with a value of 5.22%, CELL is in line with its industry, outperforming 53.57% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.42% | ||
| ROE | 3.98% | ||
| ROIC | 5.22% |
ROA(3y)-10.28%
ROA(5y)-5.5%
ROE(3y)-16.94%
ROE(5y)-9.21%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Profit Margin, with a value of 2.27%, CELL is in line with its industry, outperforming 50.00% of the companies in the same industry.
CELL's Profit Margin has declined in the last couple of years.
CELL's Operating Margin of 4.17% is in line compared to the rest of the industry. CELL outperforms 53.57% of its industry peers.
CELL's Operating Margin has declined in the last couple of years.
With a decent Gross Margin value of 40.12%, CELL is doing good in the industry, outperforming 67.86% of the companies in the same industry.
In the last couple of years the Gross Margin of CELL has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.17% | ||
| PM (TTM) | 2.27% | ||
| GM | 40.12% |
OM growth 3Y35.04%
OM growth 5Y-19.56%
PM growth 3YN/A
PM growth 5Y-23.32%
GM growth 3Y-2.78%
GM growth 5Y-2.73%
2. Health
2.1 Basic Checks
CELL has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for CELL has been reduced compared to 1 year ago.
The number of shares outstanding for CELL has been reduced compared to 5 years ago.
The debt/assets ratio for CELL has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.76 indicates that CELL is not a great score, but indicates only limited risk for bankruptcy at the moment.
CELL has a better Altman-Z score (2.76) than 60.71% of its industry peers.
The Debt to FCF ratio of CELL is 2.15, which is a good value as it means it would take CELL, 2.15 years of fcf income to pay off all of its debts.
CELL has a Debt to FCF ratio of 2.15. This is in the better half of the industry: CELL outperforms 75.00% of its industry peers.
A Debt/Equity ratio of 0.15 indicates that CELL is not too dependend on debt financing.
CELL's Debt to Equity ratio of 0.15 is amongst the best of the industry. CELL outperforms 85.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | 2.15 | ||
| Altman-Z | 2.76 |
ROIC/WACC0.61
WACC8.49%
2.3 Liquidity
CELL has a Current Ratio of 2.22. This indicates that CELL is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 2.22, CELL is in the better half of the industry, outperforming 67.86% of the companies in the same industry.
CELL has a Quick Ratio of 1.53. This is a normal value and indicates that CELL is financially healthy and should not expect problems in meeting its short term obligations.
CELL has a Quick ratio of 1.53. This is in the better half of the industry: CELL outperforms 71.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.22 | ||
| Quick Ratio | 1.53 |
3. Growth
3.1 Past
CELL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 16.66%, which is quite good.
The earnings per share for CELL have been decreasing by -20.43% on average. This is quite bad
CELL shows a small growth in Revenue. In the last year, the Revenue has grown by 3.45%.
CELL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.18% yearly.
EPS 1Y (TTM)16.66%
EPS 3YN/A
EPS 5Y-20.43%
EPS Q2Q%-6.82%
Revenue 1Y (TTM)3.45%
Revenue growth 3Y14.1%
Revenue growth 5Y3.18%
Sales Q2Q%0.93%
3.2 Future
Based on estimates for the next years, CELL will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.11% on average per year.
CELL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.54% yearly.
EPS Next Y22.5%
EPS Next 2Y15.11%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year5.99%
Revenue Next 2Y4.54%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 12.48, CELL is valued correctly.
CELL's Price/Earnings ratio is rather cheap when compared to the industry. CELL is cheaper than 89.29% of the companies in the same industry.
CELL's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.07.
The Price/Forward Earnings ratio is 6.24, which indicates a rather cheap valuation of CELL.
Based on the Price/Forward Earnings ratio, CELL is valued cheaply inside the industry as 92.86% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.59, CELL is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.48 | ||
| Fwd PE | 6.24 |
4.2 Price Multiples
CELL's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CELL is cheaper than 92.86% of the companies in the same industry.
CELL's Price/Free Cash Flow ratio is rather cheap when compared to the industry. CELL is cheaper than 96.43% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.21 | ||
| EV/EBITDA | 3.43 |
4.3 Compensation for Growth
CELL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CELL's earnings are expected to grow with 15.11% in the coming years.
PEG (NY)0.55
PEG (5Y)N/A
EPS Next 2Y15.11%
EPS Next 3YN/A
5. Dividend
5.1 Amount
CELL has a Yearly Dividend Yield of 2.94%. Purely for dividend investing, there may be better candidates out there.
CELL's Dividend Yield is rather good when compared to the industry average which is at 1.97. CELL pays more dividend than 89.29% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.46, CELL has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.94% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
33.39% of the earnings are spent on dividend by CELL. This is a low number and sustainable payout ratio.
DP33.39%
EPS Next 2Y15.11%
EPS Next 3YN/A
BIT:CELL (9/5/2025, 7:00:00 PM)
3.12
-0.01 (-0.48%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)
Earnings (Next)
Inst Owners8.42%
Inst Owner ChangeN/A
Ins Owners19.57%
Ins Owner ChangeN/A
Market Cap68.23M
Analysts82.86
Price Target4.79 (53.53%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.94% |
Yearly Dividend0.08
Dividend Growth(5Y)N/A
DP33.39%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.48 | ||
| Fwd PE | 6.24 | ||
| P/S | 0.28 | ||
| P/FCF | 4.21 | ||
| P/OCF | 3.17 | ||
| P/B | 0.5 | ||
| P/tB | 1.23 | ||
| EV/EBITDA | 3.43 |
EPS(TTM)0.25
EY8.01%
EPS(NY)0.5
Fwd EY16.02%
FCF(TTM)0.74
FCFY23.77%
OCF(TTM)0.98
OCFY31.55%
SpS11.03
BVpS6.27
TBVpS2.54
PEG (NY)0.55
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.42% | ||
| ROE | 3.98% | ||
| ROCE | 5.96% | ||
| ROIC | 5.22% | ||
| ROICexc | 5.96% | ||
| ROICexgc | 13.29% | ||
| OM | 4.17% | ||
| PM (TTM) | 2.27% | ||
| GM | 40.12% | ||
| FCFM | 6.73% |
ROA(3y)-10.28%
ROA(5y)-5.5%
ROE(3y)-16.94%
ROE(5y)-9.21%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y46.34%
ROICexcg growth 5Y-17.53%
ROICexc growth 3Y77.77%
ROICexc growth 5Y-8.95%
OM growth 3Y35.04%
OM growth 5Y-19.56%
PM growth 3YN/A
PM growth 5Y-23.32%
GM growth 3Y-2.78%
GM growth 5Y-2.73%
F-Score7
Asset Turnover1.07
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | 2.15 | ||
| Debt/EBITDA | 0.89 | ||
| Cap/Depr | 38.67% | ||
| Cap/Sales | 2.2% | ||
| Interest Coverage | 3.36 | ||
| Cash Conversion | 90.51% | ||
| Profit Quality | 296.98% | ||
| Current Ratio | 2.22 | ||
| Quick Ratio | 1.53 | ||
| Altman-Z | 2.76 |
F-Score7
WACC8.49%
ROIC/WACC0.61
Cap/Depr(3y)26.8%
Cap/Depr(5y)35.01%
Cap/Sales(3y)3.22%
Cap/Sales(5y)4.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)16.66%
EPS 3YN/A
EPS 5Y-20.43%
EPS Q2Q%-6.82%
EPS Next Y22.5%
EPS Next 2Y15.11%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.45%
Revenue growth 3Y14.1%
Revenue growth 5Y3.18%
Sales Q2Q%0.93%
Revenue Next Year5.99%
Revenue Next 2Y4.54%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y44.24%
EBIT growth 3Y54.08%
EBIT growth 5Y-17%
EBIT Next Year52.68%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y98.93%
FCF growth 3Y4.84%
FCF growth 5Y6.28%
OCF growth 1Y65%
OCF growth 3Y4.12%
OCF growth 5Y1.2%